Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin test methods.

C Breymann1

  • 1Department of Obstetrics and Gynaecology, University Hospital of Zurich, Switzerland.

Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum.

Archives of gynecology and obstetrics·2017
Same author

Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement.

Transfusion medicine (Oxford, England)·2017
Same author

Archives of gynecology and obstetrics·2016
Same author

Treatment of Iron Deficiency in Women.

Geburtshilfe und Frauenheilkunde·2015
Same author

[Anemia and thrombocytopenia: early detection of risks].

Deutsche medizinische Wochenschrift (1946)·2008
Same author

Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion.

Vox sanguinis·2007

Detecting recombinant human erythropoietin (rhEPO) abuse in sports is challenging as current methods are indirect. Relying solely on hematocrit for bans risks false positives, necessitating a battery of tests for accurate detection.

Area of Science:

  • Sports Science
  • Biochemistry
  • Anti-Doping

Background:

  • Recombinant human erythropoietin (rhEPO) doping increases red blood cell mass and is prevalent in sports.
  • Current immunoassay methods cannot distinguish between endogenous and exogenous rhEPO, making direct detection difficult.
  • Elevated rhEPO levels are transient, limiting detection windows after administration.

Purpose of the Study:

  • To evaluate the effectiveness of indirect markers for detecting rhEPO doping in athletes.
  • To highlight the limitations and risks associated with using hematocrit as the sole criterion for doping bans.
  • To advocate for a comprehensive testing strategy to improve the accuracy of rhEPO abuse detection.

Main Methods:

  • Review of current indirect detection methods for rhEPO abuse.

Related Experiment Videos

  • Analysis of hematocrit levels as a primary screening tool.
  • Examination of iron status markers (e.g., hypochromic red cells, reticulocytes, serum transferrin receptors, ferritin) and urinary fibrin degradation products.
  • Discussion of emerging direct detection assays like liquid chromatography-mass spectrometry.

    • Main Results:

    • Hematocrit levels are currently the sole basis for banning athletes for rhEPO abuse.
    • Various factors can lead to false positive hematocrit results, jeopardizing athletes' careers.
    • Iron status indices show promise but require further validation.
    • No single indirect marker offers sufficient sensitivity and specificity for reliable detection.

    Conclusions:

    • Current methods for detecting rhEPO doping are insufficient, leading to potential misidentification.
    • Over-reliance on hematocrit for bans poses significant risks due to false positives.
    • A multi-test approach combining various indirect markers is crucial for enhancing detection accuracy.
    • Development and validation of new direct assays are essential for definitive rhEPO detection in sports.